Search

Your search keyword '"Kogame A"' showing total 1,559 results

Search Constraints

Start Over You searched for: Author "Kogame A" Remove constraint Author: "Kogame A"
1,559 results on '"Kogame A"'

Search Results

3. Evolutionary genomics of the emergence of brown algae as key components of coastal ecosystems

4. Anti-interferon gamma-inducible protein 16 antibodies: Identification of a novel autoantigen in idiopathic interstitial pneumonia and its clinical characteristics based on a multicenter cohort study

5. Geographic disparity of pathophysiological coronary artery disease characteristics: Insights from ASET trials

6. THBS1-producing tumor-infiltrating monocyte-like cells contribute to immunosuppression and metastasis in colorectal cancer

7. Localized-to-itinerant transition preceding antiferromagnetic quantum critical point and gapless superconductivity in CeRh$_{0.5}$Ir$_{0.5}$In$_5$

8. THBS1-producing tumor-infiltrating monocyte-like cells contribute to immunosuppression and metastasis in colorectal cancer

9. Exploring the role of Janus kinase (JAK) in atopic dermatitis: a review of molecular mechanisms and therapeutic strategies

11. Summary of the current status of clinically diagnosed cases of Schnitzler syndrome in Japan

14. Summary of the current status of clinically diagnosed cases of Schnitzler syndrome in Japan

16. Usefulness of the 2-year iodine-123 metaiodobenzylguanidine-based risk model for post-discharge risk stratification of patients with acute decompensated heart failure

17. Diagnostic concordance and discordance between angiography-based quantitative flow ratio and fractional flow reserve derived from computed tomography in complex coronary artery disease

19. Prostatic urinary tract visualization with super-resolution deep learning models.

22. A prospective multicenter validation study for a novel angiography-derived physiological assessment software: Rationale and design of the radiographic imaging validation and evaluation for Angio-iFR (ReVEAL iFR) study

23. A treatment planning study of urethra-sparing intensity-modulated proton therapy for localized prostate cancer

27. Waves of layered immunity over innate lymphoid cells

32. Influence of Bleeding Risk on Outcomes of Radial and Femoral Access for Percutaneous Coronary Intervention: An Analysis From the GLOBAL LEADERS Trial

33. Visualizing the urethra by magnetic resonance imaging without usage of a catheter for radiotherapy of prostate cancer

34. Prognostic value of impaired hepato‐renal function and liver fibrosis in patients admitted for acute heart failure

35. Aspirin-Free Prasugrel Monotherapy Following Coronary Artery Stenting in Patients With Stable CAD: The ASET Pilot Study

36. The Impact of Coronary Physiology on Contemporary Clinical Decision Making

37. The impact of pre-procedure heart rate on adverse clinical outcomes in patients undergoing percutaneous coronary intervention: Results from a 2-year follow-up of the GLOBAL LEADERS trial

38. Association of Pulse Pressure With Clinical Outcomes in Patients Under Different Antiplatelet Strategies After Percutaneous Coronary Intervention: Analysis of GLOBAL LEADERS

39. DAPT Score and the Impact of Ticagrelor Monotherapy During the Second Year After PCI

40. Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: Pre-specified subgroup analysis from the randomized GLOBAL LEADERS study

43. Evolutionary genomics of the emergence of brown algae as key components of coastal ecosystems

45. The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial

46. Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trial

47. Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial

48. Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial)

49. Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease

50. Predictive ability of ACEF and ACEF II score in patients undergoing percutaneous coronary intervention in the GLOBAL LEADERS study

Catalog

Books, media, physical & digital resources